Juliet Agudelo

951 total citations · 1 hit paper
7 papers, 689 citations indexed

About

Juliet Agudelo is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Juliet Agudelo has authored 7 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Virology and 2 papers in Immunology. Recurrent topics in Juliet Agudelo's work include SARS-CoV-2 and COVID-19 Research (3 papers), HIV Research and Treatment (3 papers) and T-cell and B-cell Immunology (2 papers). Juliet Agudelo is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), HIV Research and Treatment (3 papers) and T-cell and B-cell Immunology (2 papers). Juliet Agudelo collaborates with scholars based in United States, United Kingdom and Germany. Juliet Agudelo's co-authors include Kai Lü, Graham Simmons, Stefan Pöhlmann, Yanchen Zhou, James H. McKerrow, Dale L. Barnard, Jerritt Nunneley, P. Vedantham, Ricardo Carrion and Adam R. Renslo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Investigative Dermatology and Virology.

In The Last Decade

Juliet Agudelo

7 papers receiving 677 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Protease inhibitors targeting coronavirus and filovirus entry

2015 437 citations Yanchen Zhou, P. Vedantham et al. Antiviral Research profile →

Peers

Countries citing papers authored by Juliet Agudelo

Since Specialization

Citations

This map shows the geographic impact of Juliet Agudelo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juliet Agudelo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juliet Agudelo more than expected).

Fields of papers citing papers by Juliet Agudelo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juliet Agudelo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juliet Agudelo. The network helps show where Juliet Agudelo may publish in the future.

Co-authorship network of co-authors of Juliet Agudelo

This figure shows the co-authorship network connecting the top 25 collaborators of Juliet Agudelo. A scholar is included among the top collaborators of Juliet Agudelo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juliet Agudelo. Juliet Agudelo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Protease inhibitors targeting coronavirus and filovirus entry breakdown → 2015 ·Antiviral Research ·Yanchen Zhou, P. Vedantham, Kai Lü, Juliet Agudelo, Ricardo Carrion, Jerritt Nunneley, Dale L. Barnard, Stefan Pöhlmann, James H. McKerrow, Adam R. Renslo, Graham Simmons	437
2	Different host cell proteases activate the SARS-coronavirus spike-protein for cell–cell and virus–cell fusion 2011 ·Virology ·Graham Simmons, Stephanie Bertram, Ilona Glowacka, Imke Steffen, Chawaree Chaipan, Juliet Agudelo, Kai Lü, Andrew J. Rennekamp, Heike Hofmann, Paul Bates, Stefan Pöhlmann	91
3	Inhibitors of SARS-CoV entry – Identification using an internally-controlled dual envelope pseudovirion assay 2011 ·Antiviral Research ·Yanchen Zhou, Juliet Agudelo, Kai Lü, David H. Goetz, Elizabeth Hansell, Yen‐Ting Chen, William Roush, James H. McKerrow, Charles S. Craik, Sean M. Amberg, Graham Simmons	19
4	Rational Peptide Selection To Detect Human Immunodeficiency Virus Type 1-Specific T-Cell Responses under Resource-Limited Conditions 2007 ·Clinical and Vaccine Immunology ·Christian B. Willberg, Satish K. Pillai, (unknown), Michael Rosenberg, Juliet Agudelo, Jason D. Barbour, Douglas F. Nixon	1
5	The Association Between HLA DR, DQ Antigens, and Vulval Lichen Sclerosus in the UK: HLA DRB112 and its Associated DRB112/DQB10301/04/09/010 Haplotype Confers Susceptibility to Vulval Lichen Sclerosus, and HLA DRB10301/04 and its Associated DRB10301/04/DQB10201/02/03 Haplotype Protects from Vulval Lichen Sclerosus 2005 ·Journal of Investigative Dermatology ·Xing‐Hua Gao, Martin Barnardo, Samantha Winsey, Tariq Ahmad, Julia Cook, Juliet Agudelo, (unknown), Jenny Powell, Susan V. Fuggle, Fenella Wojnarowska	66
6	Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS 2004 ·Proceedings of the National Academy of Sciences ·Almut Scherer, John Frater, Annette Oxenius, Juliet Agudelo, David A. Price, Huldrych F. Günthard, Martin Barnardo, Luc Perrin, Bernard Hirschel, Rodney E. Phillips, Angela R. McLean, (unknown)	71
7	Complete mapping of a novel HLA A6801-restricted HIV-1 Tat epitope directly ex vivo with a rapid modified enzyme-linked immunospot assay 2002 ·AIDS* ·Annette Oxenius, Bent K. Jakobsen, Philippa Easterbrook, Jonathan M. Boulter, (unknown), Anele Waters, Juliet Agudelo, Martin Barnardo, Rodney E. Phillips, David A. Price	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact